Machine learning-based integration reveals reliable biomarkers and potential mechanisms of NASH progression to fibrosis
Abstract Non-alcoholic fatty liver disease (NAFLD) affects about 25% of adults worldwide. Its advanced form, non-alcoholic steatohepatitis (NASH), is a major cause of liver fibrosis, but there are no non-invasive tests for diagnosing or preventing it. In our study, we analyzed data from multiple sou...
Saved in:
| Main Authors: | Jiahui Feng, Zheng Gong, Jialing Yang, Yuting Mo, Fengqian Song |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-97670-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of FDFT1 and PGRMC1 as New Biomarkers in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocellular Carcinoma by Deep Learning
by: Liu Q, et al.
Published: (2025-04-01) -
The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis
by: Xiangqi Chen, et al.
Published: (2025-08-01) -
Mini-review: Serum immunoglobulins and MASLD
by: Ke-qian Chen, et al.
Published: (2025-08-01) -
Molecular mechanisms of efferocytosis imbalance in the idiopathic pulmonary fibrosis microenvironment: from gene screening to dynamic regulation analysis
by: Qian Jin, et al.
Published: (2025-07-01) -
MAP17 is a Novel NASH Progression Biomarker Associated with Macrophage Infiltration, Immunotherapy Response, and Oxidative Stress
by: Huang Z, et al.
Published: (2025-01-01)